about
AION Labs is a venture studio built to connect pharma R&D with the next wave of AI, technology, and scientific innovation. It is a unique partnership formed by AstraZeneca, Merck, Pfizer, Teva, the Israel Biotech Fund, Amiti Ventures, and AWS.
AION Labs combines deep pharmaceutical R&D expertise with cutting-edge technology to create de-risked, industry-aligned ventures. Through its co-development model, startups gain early access to pharma insights, R&D champions, and real-world validation opportunities, alongside structured company-building support and funding.
OUR UNIQUE OFFERING
Problem & Market
Validation
We de-risk innovation through deep problem ideation and validation in close collaboration with our partners.
Unparalleled Access to Pharma
Direct engagement with leading pharma R&D experts, providing real insight into research processes, challenges, and unmet needs.
Future Technologies for Pharma R&D
Testing and validating next-generation technologies for real R&D impact
Prove Fast
Pilot execution and meaningful validation within <18 months
Pre-Seed Funding
We offer pre-seed capital to launch, validate, and reach key milestones
End-to-End Venture Support
Hands-on support beyond technology, funding, partnerships, talent sourcing, and full administrative and financial backing from ideation through growth
